SEC Form D filing
Lonestar Medicines, Inc., 2026-02-23
An SEC Form D private-offering notice from Boston, MA, a $45,000,000 filer-stated offering target in Biotech. Filed 2026-02-23. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Lonestar Medicines, Inc. Verified via SEC Form D
Filed 2026-02-23Filed to raise $45,000,000First money in 2026-01-12Raised so far $25,000,000HQ (as filed) Boston, MASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Delayed filing
Source linked the Form D on EDGAR↗Named in the filing 5 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- TBBNS LLC, 2026-02-24, $10M, Boston, MA
- Ceramic Orthopedics Inc., 2026-02-25, $2M, Bloomfield Hills, MI
- Kanewoolf, LLC, 2026-02-24, $300K, Pittsfield, MA
- Nasus Pharma Ltd, 2026-02-25, $15M, Tel Aviv
- OPERATING ROOM INNOVATIONS, INC., 2026-02-24, $1.5M, Dennis, MA
- NANOVIRICIDES, INC., 2026-02-25, $6M, Shelton, CT
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.